1 / 21

Critique of the Week : A Chronic Disease Score with Empirically Derived Weights.

Critique of the Week : A Chronic Disease Score with Empirically Derived Weights. Daniel Clark, Michael Von Kroff, Kathleen Saunders, William Baluch and Gregory Simon. Critique of the Week. Objective: To develop a Chronic Disease Score with Empirically Derived Weights

lana
Télécharger la présentation

Critique of the Week : A Chronic Disease Score with Empirically Derived Weights.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Critique of the Week: A Chronic Disease Score with Empirically Derived Weights. Daniel Clark, Michael Von Kroff, Kathleen Saunders, William Baluch and Gregory Simon.

  2. Critique of the Week • Objective: • To develop a Chronic Disease Score with Empirically Derived Weights • To compare the Revised Chronic Disease Score (empirically derived weights) with Original (physician assigned weights) CDS and ADGs • To assess associations between the Predicted Costs, Utilization, Hospitalization and Death with total costs, outpatient cost, primary visits.

  3. Critique of the Week • Significance: • To develop a reliable and more predictive Risk Adjuster for determining Capitation payments. • A wider range of medications are covered compared to the original CDS. • To asses the correlation between both the CDS and ADG to each of the outcome variable (predicted costs, utilization, hospitalization and death)

  4. Critique of the Week • Hypotheses: • Not explicitly Conveyed • Probable Hypotheses; • The Revised CDS explains more variance in Predicted Costs, Utilization, Hospitalization and Death than the Original CDS and the ADGs. • The Revised CDS predicts the Costs, Utilization, Hospitalization and Death, to a higher degree than the Original CDS and the ADGs.

  5. Critique of the Week • Data Collection: • Group Health Cooperation of Puget Sound in Western Washington State. • Adults (18 yrs or older). • Enrolled continuously at GHC for last six months of 1992. • 245,694 subjects were selected for the study.

  6. Critique of the Week • Results: • Proxy measures for Disease severity (CDS & ADGs) considerably improve prediction of health care utilization and costs. • Both the Revised CDS and ADGs were equal in predicting primary visits and costs. • Revised CDS was best in prediction mortality.

  7. Critique of the Week • Results

  8. Critique of the Week • Results: • Variance explained in concurrent models was higher then the Variance explained for the Prospective period. • There was no clear better predictor (CDSs or ADGs) for the outcome variables.

  9. Critique of the Week • Results

  10. Critique of the Week • Results • For Concurrent Model; • No improvement over the revised CDS was found for total cost. • There was only marginal improvement in variance explained with the incorporation of ADGs and the original CDS into the same model.

  11. Critique of the Week • Results • For the Prospective Model; • Improved prediction was achieved by the revised CDS relative to the original CDS • ADGs performed better on all outcomes in the concurrent model but the revised CDS performed slightly better in explained variance in total and outpatient costs

  12. Critique of the Week • Results • Odds Ratio for Death and Hospitalization were estimated from predicted costs and Utilization. • The Revised CDS had stronger correlation with death than ADGs, Original CDS had the weakest correlation.

  13. Critique of the Week Results Odds Ratio. • The odds ratio is a way of comparing whether the probability of a certain event is the same for two groups. • An odds ratio of 1 implies that the event is equally likely in both groups. • An odds ratio greater than one implies that the event is more likely in the first group. • An odds ratio less than one implies that the event is less likely in the first group.

  14. Critique of the Week • Level of Study: Exploratory and Descriptive • Time Frame: Ex post facto (retrospective)

  15. Critique of the Week • Operational definitions: • Not clearly given. • Assumed knowledge of various standardized Disease Severity Scores (CDSs, ADGs…etc). • Methods used were well documented and were adequate for reproducibility.

  16. Critique of the Week • Methods: • A Revised CDS was created using Regression model using medication usage and age and gender, for a random half of the population. • Parameters associated with each medication variable were estimated for each of three outcomes: outpatient cost, primary care visits and total costs.

  17. Critique of the Week • Methods: • These weights were then used to calculate a predicted score for total cost, Outpatient cost and primary care visits for the other half of the population. • The weights were also used to predict the outcome parameters for a Prospective Cohort. • The Predicted parameters were then correlated with the actual parameters. Also the Scores were correlated with risk of Hospitalization and Death.

  18. Critique of the Week • Controls • Randomization • Testing the Regression model Scores on both Concurrent and Prospective gorups.

  19. Critique of the Week • Identified Sources of Bias. • Revised CDS obtained from six months data compared to twelve data for Original CDS. • Not all enrollees had medications filled in the six month period. • Manipulation. • Endogeneity.

  20. Critique of the Week • Generalizability: That particular Health Maintenance Organization (HMO). • Future Study: Testing and Validating the Revised CDS at different sites than the one used here.

  21. Critique of the Week • Weak Research Methodology • Typical of a Pharmacoeconomic Study • Strong yet Simple statistical methods • Least Square Regression • Odds Ratio

More Related